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Background: N-myc down-regulated gene 2 (NDRG2) is a tumor suppressor involved in cell proliferation and
differentiation. The aim of this study was to determine the uterine expression pattern of this gene during early
pregnancy in mice.
Methods: Uterine NDRG2 mRNA and protein expression levels were determined by RT-PCR and Western blot analyses,
respectively, during the peri-implantation period in mice. Immunohistochemical (IHC) analysis was performed to
examine the spatial localization of NDRG2 expression in mouse uterine tissues. The in vitro decidualization model of
mouse endometrial stromal cells (ESCs) was used to evaluate decidualization of ESCs following NDRG2 knock down
by small interfering RNA (siRNA). Statistical significance was analyzed by one-way ANOVA using SPSS 19.0 software.
Results: Uterine NDRG2 gene expression was significantly up-regulated and was predominantly localized to the
secondary decidual zone on days 5 and 8 of pregnancy in mice. Its increased expression was associated with artificial
decidualization as well as the activation of delayed implantation. Furthermore, uterine NDRG2 expression was
induced by estrogen and progesterone treatments. The in vitro decidualization of mouse ESCs was accompanied
by up-regulation of NDRG2 expression, and knock down of its expression in these cells by siRNA inhibited the
decidualization process.
Conclusions: These results suggest that NDRG2 might play an important role in the process of decidualization during
early pregnancy.
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Successful embryo implantation is a critical step in the es-
tablishment of pregnancy. Failure of implantation can lead
to placental dysfunction, resulting in fetal retardation, pre-
eclampsia (PE), and recurrent miscarriages [1, 2]. A series
of complex physiological events occur during the exqui-
sitely regulated process of implantation, including blasto-
cyst migration, apposition and adhesion to the luminal
epithelium, extensive degradation and remodeling of the* Correspondence: zhangxuancw@outlook.com; wangjiansippr@126.com
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unless otherwise stated.extracellular matrix, and invasion of trophoblast cells into
the maternal endometrium, as well as decidualization of
endometrial stromal cells (ESCs) [3, 4]. Decidualization,
characterized by proliferation and differentiation of ESCs,
is a postovulatory process of endometrial remodeling that
occurs in preparation for pregnancy. In addition, during
pregnancy, the maternal decidua is essential for the estab-
lishment and maintenance of immuno-tolerance at the
feto-maternal interface, and it regulates placental function
and development of the conceptus [5, 6]. However, the
exact molecular mechanism underlying decidualization is
still unclear. The identification of the factors involved ins is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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understanding of the implantation process.
N-myc, which belongs to the Myc family, plays an essen-
tial role in cell proliferation and differentiation. Although
N-myc has been well recognized for its oncogenic bio-
function, it has been recently reported to exhibit a dynamic
expression pattern during mouse embryonic development
[7]. N-Myc downstream-regulated gene 2 (NDRG2), a
member of the N-Myc downstream-regulated gene family,
encodes a 357-amino acid protein with an apparent mo-
lecular weight of 41 kDa [8]. Consistent with its role in
cellular differentiation and the stress response, NDRG2
has been identified as a tumor suppressor. Specifically, its
expression has been shown to be decreased in a number
of different cancer tissues, such as breast [9], liver [10]
and gastric cancer tissues [11]. Its expression has also
been detected in mouse embryos of various gestational
ages. Further, during mouse fetal development, NDRG2
has been found to be strongly expressed in various tissues
and organs [12], suggesting its potential role in embryonic
development. This gene is phosphorylated by protein kin-
ase B (PKB/Akt), PKC [13], and glucocorticoid-induced
kinase 1 (SGK1) [14]. Akt/PKC signaling is a key regulator
of trophoblast function during implantation as well as
during early placentation [15]. Thus, we hypothesized that
NDRG2 might be involved in the process of embryo
implantation, and the present study was undertaken to
examine the uterine expression pattern of this gene during
the estrous cycle and peri-implantation period in mice.
Methods
Animals and tissue preparation
Adult ICR mice aged 8-10 weeks were obtained from
the SIPPR/BK Laboratory Animal Company (Shanghai,
China) and were caged at a controlled temperature (22 °C)
under a 14 h light: 10 h dark photoperiod. All experiments
were conducted in full compliance with standard labo-
ratory animal care protocols that were approved by the
Institutional Animal Care Committee of Shanghai Institute
of Planned Parenthood Research (Approval: 2013-19).
The estrous cycle was staged by examining vaginal
smears as previously described [16], and subsequently
the uterine horns were removed from adult females at
the diestrus, proestrus, estrous, and metestrus stages
(n = 3, per stage) immediately after they were sacrificed
by cervical dislocation.
To observe the effects of ovarian steroid hormones on
uterine NDRG2 expression, adult females were ovariecto-
mized and allowed to rest for 2 weeks. Then, the ovariecto-
mized mice were randomly divided into four groups (n = 3,
per group) and injected with (1) sesame oil (0.1 ml/mouse),
(2) 17β-estradiol (E2, 100 ng/25 g body weight, Sigma,
St. Louis, MO), (3) progesterone (P4, 1 mg/25 g body
weight, Sigma), or (4) E2 (100 ng/25 g body weight) plusP4 (1 mg/25 g body weight) according to previously de-
scribed methods [17–19]. Steroids were dissolved in ses-
ame oil and injected subcutaneously at the same volume
(0.1 ml/mouse). The mice were sacrificed at 24 h after
treatment, and the uterine horns were collected.
Adult female mice were mated with fertile males of
the same strain to achieve pregnancy (day 1 = day of
vaginal plug). Pregnancy was confirmed on days 1 and 4
by recovering embryos from the reproductive tracts.
Trypan blue dye solution (0.1 % in saline (w/v), 0.1 ml
per mouse, Sigma) was injected via the tail vein on day 5
to visualize the implantation sites. The entire uterine
horn was collected from the pregnant mice on days 1
and 4 of pregnancy (n = 3, per day). Uterine tissues at
the implantation sites (IS) and non-implantation sites
(NI) were separately collected from the pregnant mice
on days 5 to 8 of pregnancy (n = 3, per day).
Pseudopregnant mice were obtained by mating adult
females with vasectomized adult males. Artificial decidua-
lization was induced by intraluminally infusing 25 μl of
sesame oil into one uterine horn on day 4 of pseudopreg-
nancy (n = 3), and the contralateral un-injected horn
served as a control (n = 3). The mice were sacrificed at
72 h after decidualization was artificially induced [20].
Decidualization was confirmed by both weighing the uterine
horns and histological examination of the uterine sections.
In the delayed embryo implantation model, pregnant
female mice were bilaterally ovariectomized under ether
anesthesia at 08:30–09:00 h on day 4 of pregnancy. The an-
imals in the delayed embryo implantation group and acti-
vation group were subcutaneously injected with P4 (1 mg/
25 g body weight) dissolved in corn oil at 10:00 h from
days 4 through 7 of pregnancy to maintain delayed im-
plantation. Then, the animals in the activated implantation
group (n = 3) received E2 (25 ng/25 g body weight) along
with P4 to activate embryo implantation [20, 21]. The
female mice were euthanized at 10:00 h on day 8 of
pregnancy, and the embryos were verified as previously de-
scribed [22]. Delayed or activated implantation was con-
firmed by microscopic observation of the metabolically
dormant or activated blastocyst in the uterine flush, as pre-
viously described [20]. Progesterone keeps the blastocyst
dormant so that the inner cellular mass (ICM) remains
underdeveloped. However, when estradiol is supplied with
progesterone, the blastocyst becomes active, and the ICM
becomes more prominent and distinct in appearance
[20, 23, 24]. The uterine tissues were collected and then
processed for RNA extraction and immunohistochemistry.
Primary culture of endometrial stromal cells and
induction of decidualization in vitro
The isolation and culture of mouse ESCs was performed
following previously described methods with minor
modifications [25]. In summary, uterine horns were
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remove fat tissues. They were then slit longitudinally
and washed thoroughly in Hanks’ balanced salt solution
(HBSS, Invitrogen, Carlsbad, CA) containing 100 U/ml peni-
cillin (Invitrogen) and 100 μg/ml streptomycin (Invitrogen).
Next, the tissues were placed in HBSS containing 10 mg/ml
trypsin (Sigma), 6 mg/ml dispase (Invitrogen), 100 U/ml
penicillin and 100 μg/ml streptomycin for 1 h on ice,
followed by incubation for 1 h at room temperature and
10 min at 37 °C. Following the digestion steps, the tissues
were gently mixed, and the supernatant was discarded to
remove the endometrial epithelial clumps. The partially
digested tissues were then washed twice in HBSS and
placed into HBSS containing 0.15 mg/ml collagenase
(Invitrogen) at 37 °C for 30 min. Following digestion and
shaking, the contents of the tube were passed through a
70 μm gauze filter (Millipore, Darmstadt, Germany) to
eliminate epithelial sheets. The cell pellets were washed
twice and added to Dulbecco’s modified Eagle’s Medium-
F12 medium (DMEM/F12) containing 10 % charcoal-
stripped fetal calf serum (FBS, Invitrogen) and antibiotics
at 2 × 105 cells per well in a 6-well cell culture plate
(Invitrogen). After incubation for 1 h, unattached cells
were removed by several washes with HBSS, and cell cul-
turing was continued after the addition of fresh DMEM/
F12 containing 1 % charcoal-stripped FBS, 100 U/ml peni-
cillin, 100 μg/ml streptomycin, 10 nM E2, and 1 μM P4 to
induce decidualization of the ESCs.
siRNA transfection
NDRG2-targeting siRNAs were purchased from Santa
Cruz Biotechnology, Inc. (NDRG2 siRNA (m) sc-40758,
and sc-3700 7was used as the irrelevant control siRNA,
Santa Cruz, Santa Cruz, CA). Prior to the in vitro deci-
dualization of ESCs, NDRG2 siRNAs and control siRNAs
were transfected into cultured ESCs according to the
siPORT™ NeoFX™ protocol (Ambion/Life Technologies,
Grand Island, NY). Briefly, 4 μl of siPORT NeoFX trans-
fection reagent was mixed with 100 nM of siRNA du-
plexes to form complexes, and this mixture was then
dispersed into each well of a 6-well cell culture plate.
Immunohistochemistry and histological analyses
Uterine tissues were fixed in freshly prepared 4 % buffered
paraformaldehyde in phosphate-buffered saline (PBS) at
4 °C for over 40 h. Then, the tissues were dehydrated in
graded alcohol and embedded in paraffin (Leica, Wetzlar,
Hessen, Germany). Sections of uteri were processed for
immunohistochemical detection. Briefly, the sections
(5 μm) were deparaffinized and rehydrated in xylene and a
graded series of ethyl alcohol, respectively, and then rinsed
in PBS. Antigen retrieval was performed by placing the
slides in boiling citric acid buffer (10 mmol/l of citrate
sodium and 10 mmol/l of citric acid) for 15 min. Thesections were cooled to room temperature and sequen-
tially incubated at room temperature with 3 % hydrogen
peroxide (H2O2) in methanol for 15 min to quench en-
dogenous peroxidases. The sections were then incubated
with a rabbit anti-NDRG2 primary antibody (Abcam,
Cambridge, UK) overnight at 4 °C. After being washed
with PBS, the sections were incubated with a biotin-
conjugated donkey anti-rabbit secondary antibody (1:200
in blocking solution, Proteintech Company, Wuhan,
China). After another wash in PBS, they were incubated
with peroxidase-conjugated streptavidin (1:200 in blocking
solution, Proteintech Company) for 2 h. Then, they were
stained with DAB (DAB, Zhongshan Corp., Beijing, China)
according to the manufacturer’s protocol and counter-
stained with hematoxylin (Sigma). For the negative con-
trols, 10 % donkey serum was used instead of primary
antibody. All the sections were examined and photo-
graphed under a microscope (DFC420C, Leica).
For vimentin and cytokeratin detection, cultured ESCs
were washed in PBS and fixed with PBS containing 4 %
paraformaldehyde for 20 min. After being washed in
PBS, the cells were incubated in blocking buffer (0.2 %
Triton-X100 and 10 % BSA in PBS) for 1 h. Next, they
were incubated with blocking buffer containing an anti-
vimentin mouse monoclonal antibody (1:100 dilution,
Cell Signaling, Beverly, MA), anti-cytokeratin 8 mouse
monoclonal antibody (1:50 dilution, Cell Signaling), or
negative control mouse IgG antibody at 4 °C overnight.
After another wash in PBS, the cells were incubated in
blocking buffer containing a biotin-conjugated donkey anti-
rabbit antibody (1:200 in blocking solution, Proteintech
Company) for 30 min. Then, the cells were again washed
in PBS and incubated with peroxidase-conjugated strepta-
vidin (1:200 in blocking solution, Proteintech Company)
for 2 h. Next, the samples were stained with DAB (DAB,
Zhongshan Corp.) according to the manufacturer’s pro-
tocol. Finally, after being washed and stained with he-
matoxylin, the cells were observed and photographed
under a microscope (DFC420C, Leica).
Real-time PCR analysis
Total RNA was extracted from uterine tissues or ESCs
using TRIzol reagent (Invitrogen) according to the manu-
facturer’s instructions. Extracted RNA was dissolved in
diethylpyrocarbonate (DEPC, Sigma)-treated water, and the
RNA concentration and purity were estimated by measu-
ring absorbance at 260 and 280 nm with a NanoDrop
2000 (Thermo Scientific, Waltham, MA). cDNAs was
synthesized using M-MLV reverse transcriptase (Promega,
Madison, WI), according to the manufacturer’s ins-
tructions. Real-time PCR was performed in a 20 μl reac-
tion volume using an ABI 7500 thermal cycler (Applied
Biosystems, Foster City, CA). The thermal cycling condi-
tions were 95 °C for 30 s, followed by 40 cycles at 94 °C
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gel electrophoresis were then conducted to monitor
the purity of the PCR products. Beta-actin was used as
an endogenous control. The following primers were
used: NDRG2, sense, 5′-AGAACTTCGTGCGGGTT
CAT-3′, antisense, 5′-TCGCGACAGAATGTAGGCTC-3′;
decidual/trophoblast PRL-related protein (DTPRP), sense,
5′-AAGAATGCCCTTCAGCGAGC-3′, antisense, 5′-AG




The collected uterine tissues were quickly frozen in
liquid nitrogen and granulated into a fine powder. The
tissue powder was homogenized in lysis buffer (Beyotime,
China). Then, the tissue lysate was centrifuged, and the
supernatant was transferred into a new tube. Cultured
ESCs were collected in lysis buffer, and the lysate was cen-
trifuged to collect the supernatant. Protein concentrations
were measured by Bradford assay (Bio-Rad, Hercules,
CA), and 50 μg of total protein was separated on a 12 %
acrylamide gel and then transferred electrophoretically
onto nitrocellulose membranes (Millipore). The mem-
branes were incubated overnight at 4 °C with specific
primary antibodies against NDRG2 and beta-actin (Santa
Cruz), followed by incubation with the appropriate
secondary antibodies. The blot was developed using a
PhosphaGLO AP Substrate Kit (KPL, Gaithersburg, MD)
according to the manufacturer’s protocol. All samples
were analyzed by Western blot in triplicate. Band inten-
sities were quantified by densitometry using ImageJ soft-
ware (U.S. National Institutes of Health, MD).
Statistical analysis
All values were presented as the mean ± SEM, as deter-
mined from at least three independent experiments.
Statistical significance was assessed by one-way ANOVA.
A P < 0.05 was considered statistically significant. Statis-
tical analysis was conducted using SPSS 19.0 software
(SPSS Software, Chicago, IL).
Results
Uterine NDRG2 expression during the estrous cycle and
peri-implantation period
The uterine expression patterns of NDRG2 mRNA and
NDRG2 protein during the mouse estrous cycle were de-
termined by real-time PCR and IHC, respectively. The
results showed distinctive NDRG2 protein signals in
luminal and glandular epithelial cells at the diestrus
(Fig. 1a), proestrus (Fig. 1b), estrous (Fig. 1c) and metes-
trus phases (Fig. 1d), with the most prominent expres-
sion detected during the estrous phase, along with weak
positive signals in stromal cells (Fig.1c). Consistently,real-time PCR analysis revealed that NDRG2 mRNA ex-
pression was significantly increased during the estrous
phase compared with that during the diestrus, proestrus
and metestrus phases (Fig. 1e).
Prior to the initiation of implantation, uterine NDRG2
mRNA expression gradually increased from day 1 (D1) to
day 4 (D4) of pregnancy. During implantation (day 5 to
day 8 of pregnancy), NDRG2 mRNA expression was dif-
ferentially regulated between the implantation sites and
non-implantation sites. Its expression was significantly
up-regulated at the implantation sites, whereas it was
obviously down-regulated at the non-implantation sites
(Fig. 2a). Meanwhile, the results of Western blot analysis
showed that uterine NDRG2 protein expression was sig-
nificantly increased after the initiation of implantation (day
5 of pregnancy), and its expression at the implantation sites
was remarkably higher than that at the non-implantation
sites (Fig. 2b). Furthermore, the spatiotemporal expression
of NDRG2 protein in the mouse uterus during early preg-
nancy was examined by IHC. There was no detectable
NDRG2 protein signal in the uterine tissue obtained from
pregnant mice on day 1 (Fig. 2c/b) or day 3 (Fig. 2c/c). On
day 4 of pregnancy, faint NDRG2 protein signals were
noted in the subepithelial stromal bed (Fig. 2c/d). On day 5
of pregnancy, the distinct accumulation of NDRG2 protein
signals was observed in both the secondary decidual zone
and the embryo, with faint expression in the primary de-
cidua immediately adjacent to the implanting embryo
(Fig. 2c/e, f). The distribution of NDRG2 protein signals
on day 8 of pregnancy was similar to that on day 5, except
that the positive signals also accumulated in trophoblasts
at implantation sites (Fig. 2c/g, h).
The effects of steroid hormones on NDRG2 expression in
the uterus
Ovariectomized mice were used to examine the effects of
steroid hormones on NDRG2 expression in the uterus.
Compared with the control (Fig. 3a), treatment with E2
(Fig. 3b) or P4 (Fig. 3c) significantly induced NDRG2 pro-
tein expression in both the luminal and glandular epithe-
lia, and the combined administration of E2 and P4 resulted
in a similar effect on its expression (Fig. 3d). A similar
alteration in NDRG2 mRNA expression was observed
following treatment with E2 or P4 (Fig. 3e).
The association of uterine NDRG2 expression and artificial
decidualization and activated implantation
The artificial decidualization model was used to examine
whether uterine NDRG2 expression is dependent on the
presence of a living embryo or whether it is induced by
the decidualization reaction alone. The results of IHC ana-
lysis showed strong NDRG2 protein signals in decidua-
lized stromal cells (Fig. 4b), whereas no visible signals
were found in control uteri (Fig. 4a). Meanwhile, uterine
Fig. 1 NDRG2 expression in the mouse uterus during the estrous cycle. Upper: immunohistochemical analysis of NDRG2 expression during the
diestrus (a), proestrus (b), estrous (c) and metestrus (d) phases in the mouse uterus. Below: quantitative PCR analysis of NDRG2 mRNA expression
(e) in the uterus during the estrous cycle (n = 3). The thick arrow shows the luminal epithelium. The small arrow indicates the glandular epithelium.
The columns with different superscripts are significantly different (P < 0.05)
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cantly up-regulated by artificial decidualization (Fig. 4c).
In the delayed implantation model, the NDRG2 protein
was abundantly expressed in activated implantation uteri
(Fig. 4e), and it was weakly expressed in delayed implant-
ation uteri (Fig. 4d). Likewise, significantly higher NDRG2
mRNA levels were detected in the activated implantation
uteri compared with those in the delayed uteri (Fig. 4f).
NDRG2 expression in cultured ESCs during the process of
in vitro decidualization
To explore the function of NDRG2 in the decidualiza-
tion of mouse ESCs, a mouse primary ESCs culturesystem was established. Positive staining for vimentin
and negative staining for cytokeratin were considered to
be indicative of ESC purity (Fig. 5a). The transformation
of decidual cells from ESCs was indicated by DTPRP
mRNA expression [26] (Fig. 5b). The mRNA and protein
levels of NDRG2 were found to be significantly in-
creased during in vitro decidualization (Fig. 5c, d).
The effects of decreased NDRG2 expression in ESCs on
in vitro decidualization
To further explore the role of NDRG2 in the deciduali-
zation of ESCs, NDRG2 expression was knocked down
in cultured ESCs using targeting siRNAs. As a result, its
Fig. 2 NDRG2 expression in the mouse uterus during early pregnancy. a Quantitative PCR analysis of NDRG2 mRNA expression in the uterus
during early pregnancy (n = 3, *P < 0.05). b Western blot and densitometric analyses of uterine NDRG2 protein levels during early pregnancy
(n = 3). All experiments were repeated three times. The data are shown as the mean ± SEM. *P < 0.05. c Immunohistochemical analysis of uterine
NDRG2 protein expression on days 1, 3, 4, 5, and 8 of pregnancy. IS, implantation sites; NI, non-implantation sites. *, indicates the location of the
embryo. le, luminal epithelium; ge, glandular epithelium; st, stroma; pdz, primary decidual zone; sdz, secondary decidual zone; D, day of pregnancy;
gc, giant cell; Scale bar represents 100 μm
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siRNA-transfected ESCs compared with that in control
ESCs (Fig. 6a, c, d), and this reduction was correlated
with a significant decrease in DTPRP mRNA expression
(Fig. 6b), indicating that down-regulation of NDRG2
expression inhibited the decidualization of mouse ESCs.
Discussion
The present study demonstrated the expression pattern
of NDRG2 in the uterus during the estrous cycle and
early pregnancy in mice. Uterine NDRG2 expression was
found to peak during the estrous phase and to be
induced by the ovarian steroid hormones E2 and P4.
During early pregnancy, uterine NDRG2 expression was
significantly increased at implantation sites, with pre-
dominant localization in the decidual zone. This increase
in expression was accompanied by the activation of
delayed implantation, as well as artificially induced de-
cidualization, both in vivo and in vitro. Furthermore,
down-regulation of NDRG2 expression in mouse ESCs
significantly inhibited decidualization in vitro.
The synergistic actions of E2 and P4 are critical for regu-
lation of the estrous cycle and establishment of uterine
receptivity [27, 28]. A putative estrogen-response element
(ERE) is located in the promoter region of the NDRG2
gene, and NDRG2 expression in astrocytes is regulated byestrogen [29, 30]. In the present study, we found that both
E2 and P4 had stimulatory effects on uterine NDRG2
expression in ovariectomized mice (Fig. 3). In addition,
during the normal estrous cycle, uterine NDRG2 expres-
sion was significantly increased during the proestrus and
estrous phases, whereas it was decreased during the
metestrus and diestrus phases (Fig. 1), consistent with the
E2 surge that takes place during the proestrus and estrous
phases [31]. Because NDRG2 expression was detected in
luminal and glandular epithelial cells as well as in stromal
cells, we speculated that it might participate in regulating
cyclic proliferation and differentiation in endometrial
epithelial/stromal cells to optimally prepare for embryo
implantation under the control of E2 and P4 during the
estrous cycle.
Successful embryo implantation is integral to the es-
tablishment of pregnancy, and initiation of implantation
coincides with the establishment of uterine receptivity
and the subsequent decidualization of endometrial stro-
mal cells (ESCs) [32]. In the mouse, a pre-ovulatory E2
surge stimulates uterine epithelial cell proliferation on
day 1 of pregnancy, followed by a rise in the P4 level and
its secretion by the newly formed corpora lutea, which
initiates uterine stromal cell proliferation on day 3. Em-
bryos enter the uterus at midnight on day 3 or in the
early hours of day 4 after the uterus is exposed to an
Fig. 3 The effects of steroid hormones on NDRG2 expression in the uterus. Upper: immunohistochemical analysis of NDRG2 protein expression in
the uteri of ovariectomized mice after oil (a), progesterone (b), estrogen (c), and progesterone plus estrogen treatments (d). Below: quantitative
PCR analysis of NDRG2 mRNA expression (e) in the uterus following steroid hormone treatment (n = 3). The thick arrow indicates the luminal
epithelium. The small arrow shows the glandular epithelium. The columns with different superscripts are significantly different (P < 0.05)
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followed by exposure to estrogen, causing it to be recep-
tive for embryo implantation [33]. We found that uterine
NDRG2 expression remained increased during the pre-
implantation period from day 1 to day 4, suggesting its
potential role in establishing uterine receptivity under
the regulation of ovarian steroids.
Once mouse embryos attach to a receptive endomet-
rium, decidualization is triggered by extensive prolifera-
tion and differentiation of ESCs into decidual stromal
cells (DSCs) at embryo implantation sites. Because the
decidual response can be induced in a reproducible
manner in the absence of an embryo and decidual zones
are easily discernable, the mouse is a good model toinvestigate the mechanism of decidualization. In the
mouse, at least three factors may be necessary for nor-
mal decidualization, including E2, P4 and embryonic or
physical stimulation (by intra-luminal infusion of oil or
scratching with a needle). Increases in E2 and P4 sti-
mulate the proliferation and differentiation of ESCs
surrounding invading trophoblast cells to support the
decidualization process [33–35]. In the present study, a
significant increase in NDRG2 expression was observed
at implantation sites on days 5 and 8 of pregnancy in the
mice, and NDRG2 protein signals were predominantly
localized to the decidual zone. Moreover, because E2 and
P4 induced NDRG2 expression in the uterus and increased
its expression in ESCs following artificial decidualization
Fig. 4 Uterine NDRG2 expression following artificial decidualization and activation of delayed implantation. Immunohistochemical analysis of
uterine NDRG2 protein expression following artificial decidualization (b) and in its contralateral uninjected uterine horn (a), under delayed implantation
(d) and activation (e). Quantitative PCR analysis of NDRG2 mRNA expression in the uterus following artificial decidualization (c) and activation of
delayed implantation (f) (n = 3). The thick arrow indicates the luminal epithelium. The small arrow shows the glandular epithelium. De, decidua;
*, significantly different from control (P < 0.05)
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volved in the decidualization of these cells. To further in-
vestigate this hypothesis, we specifically knocked down
NDRG2 expression in mouse ESCs using NDRG2-
targeting siRNAs and subsequently evaluated the effect
of decreased NDRG2 expression on ESC decidualization
in vitro using DTPRP as a marker of decidualization.
Decreased expression of this gene was found to remark-
ably inhibit decidualization in vitro (Fig. 6), indicating
that it may participate in this process.
An implantation site is distinguished from a non-
implantation site not only by the presence of DSCs and
trophoblast cells but also by the enrichment of decidual
immune cells. Dendritic cells (DCs) are the most predom-
inant immune cells in decidua at implantation sites, and
they play a critical role in preserving a hospitable micro-
environment for pregnancy [36]. Although NDRG2
expression in decidual DCs has not been reported, its
expression in DCs derived from CD34+ progenitor cells
has been detected. Inhibition of DCs differentiation isaccompanied by reduced NDRG2 expression, and the
down-regulation of its expression negatively affects the
ability of DCs to stimulate T cells proliferation [37]. Thus,
an increased in NDRG2 expression at implantation sites
during early pregnancy might also be associated with the
differentiation and maturation of decidual DCs. NDRG2
expression in decidual DCs will be explored further by
our group.
Although the exact role of NDRG2 in regulating ESCs
and DSCs needs to be further explored, NDRG2 has
been reported to contain several potential phospho-
rylation sites and to be phosphorylated by Akt [13] and
SGK1 [14]. Importantly, a decrease in uterine Akt ex-
pression has been shown to result in abnormal deci-
dualization in mice [38], and reduced SGK1 expression
in DSCs has been observed in recurrent spontaneous
miscarriage (RSM) patients [39]. Thus, it is reasonable
to believe that the function of NDRG2 in ESCs and
DSCs might be partially regulated by the Akt or/and
SGK1 signaling pathway(s). Conversely, the appropriate
Fig. 5 In vitro decidualization of mouse primary ESCs. ESCs isolated from the uteri of day 4 pregnant mice were cultured in the presence of P4
and E2. a Immunocytochemical detection of vimentin and cytokeratin in cultured ESCs. b Quantitative PCR analysis of DTPRP mRNA expression in
ESCs cultured for up to 72 h. c Western blot analysis of NDRG2 protein expression in ESCs cultured for up to 72 h. Densitometric analyses of
NDRG2 at each time point compared with 0 h is shown. d Quantitative PCR analysis of NDRG2 mRNA expression in cultured ESCs. The relative
fold induction of NDRG2 mRNA expression at each time point compared with its expression in the 0 h sample is shown. The values represent the
mean ± SEM, as determined from three separate experiments. *, significantly different (P < 0.05)
Fig. 6 Down-regulation of NDRG2 expression in ESCs inhibits in vitro decidualization. Cultured mouse ESCs were transfected with NDRG2-targeting siRNAs
(100 nM) (a non-targeting siRNA was used as a control) at the time of plating. Quantitative PCR analyses of NDRG2 mRNA expression (a) and DTPRP mRNA
expression (b) in ESCs transfected with NDRG2-targeting siRNAs or non-targeting siRNAs at 24 h and 48 h. Western blot (c) and densitometric
analyses (d) of NDRG2 protein levels in ESCs at 72 h after transfection. The relative fold induction of NDRG2 protein expression compared with
its expression in non-siRNA-treated group is shown. The values represent the mean ± SEM, as determined from three separate experiments.
*, significantly different (P < 0.05)
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a pivotal event that occurs during implantation [40].
Because we observed NDRG2 protein expression in
trophoblast cells at implantation sites on day 8 of preg-
nancy in the mice in this study (Fig. 2) and it has been
demonstrated that E2 and P4 participate in the regulation
of trophoblast cells [41, 42], we hypothesize that NDRG2
might also be involved in the invasion of trophoblast
cells during early pregnancy.
Conclusions
In summary, the present study has demonstrated that
steroid hormones stimulate NDRG2 expression in the
uterus and that NDRG2 expression is significantly up-
regulated at implantation sites during early pregnancy in
mice. During in vivo and in vitro artificial decidua-
lization, NDRG2 expression was found to be remarkably
increased. Further, down-regulation of its expression in
ESCs inhibited in vitro decidualization. These results
suggest that NDRG2 might be essential for embryo im-
plantation and decidualization.
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